Good news! The second batch of anti-cancer drugs and rare disease drug raw materials will have zero tariff next year. Why are these drugs expensive?

The raw materials for anti-cancer drugs and rare disease drugs are expensive because most of these drugs are imported and have very high tariffs. In addition, the drugs are scarce, making these drugs expensive. 1: The benefits of zero tariffs

Most anti-cancer drugs in China are imported drugs. Implementing zero tariffs on imported drugs will reduce the burden on domestic patients, especially cancer patients, and then promote drug approval, production, sales, etc. A series of reforms have benefited many patients, met the needs of cancer patients for drugs, improved domestic medical standards, and improved the medical drug supply system. Therefore, zero tariffs benefit the country and the people. 2: The reason why anti-cancer drugs are expensive

The reason why anti-cancer drugs are expensive is that the production cost is high. Anti-cancer drugs are different from ordinary drugs. Each one requires a lot of time, energy, talent and technology. To dig, the scientific research teams of pharmaceutical companies need to constantly search for the most effective ingredients from various substances. The difficulties can be imagined. In addition, most of these drugs are from non-existence to existence, and the failure rate is extremely high. It is possible to invest A large amount of money, human resources, and scientific and technological research failed to successfully develop items. Secondly, drugs are scarce. As can be seen from the above, the research and development of such drugs is very difficult. Therefore, items are scarce, and most anti-cancer drugs are imported from foreign countries. Drugs themselves are scarce and very expensive in a word. Add in import tariffs. How can such a series of procedures be inexpensive? Therefore, zero tariffs will help domestic patients have medicines that can be treated and afford them, which will benefit the country and the people. Third, the patent protection period for drugs is generally 20 years. However, this 20 years is not calculated from the time it is launched, but from the early clinical trials. Therefore, by the time the drug is launched, more than half of the patent protection period has passed. , so in order to make a profit, generally pharmaceutical companies will increase drug prices and try to recover the cost and profit of drug research and development as much as possible. After all, pharmaceutical companies are not charities and they also need to make money.

The country's implementation of zero tariffs on anti-cancer drugs and the inclusion of anti-cancer drugs in medical insurance will help improve my country's drug supply system so that cancer patients can have medicines available and afford them.